“dragonfly-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact 11/14/18 Boston
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award 08/07/18 Boston
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Skyhawk Lands $100M from Funding & Celgene Pact for RNA-Targeted Drugs 06/26/18 Boston
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney 01/23/18 Boston
Last Chance to Save on Boston’s Life Science Disruptors 09/20/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists 08/14/17 Boston
Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28 08/09/17 Boston
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Page 1 of 1